Second-guessing

WASHINGTON - Based on phone calls to BioCentury last week, readers were wont to second-guess the deliberations of the Central and Nervous System Drugs Advisory Committee on Genentech Inc.'s Activase and Cephalon Inc.'s Myotrophin.

Their questions included: ...